Extracellular Matrix Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Raw Material (Bovine, Porcine, and Other Raw Material) and Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)
Publication Month: Dec 2021 | Report Code: TIPRE00004925 | No. of Pages: 160 | Category: Medical Device | Status: Published
The extracellular matrix market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028.
The extracellular matrix is present in the outer side of the tissues, and it helps tissues bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans, and proteoglycans. Extracellular matrix enables recipient cells to regrow, and thus, it is used in various applications, including cardiac and vascular repair procedures. Several factors, such as the significant rising incidence of cardiovascular diseases and trauma and an increase in vascular reconstruction procedures, are boosting the extracellular matrix market growth. However, the challenges during the usage of decellularized extracellular matrix hamper the market's growth.
Strategic Insights
Lucrative Regions for Extracellular Matrix Market
Get more information on this report :
Market Insights
Rising Incidences of Cardiovascular Disorders and Trauma Boosts Extracellular Matrix Market Growth
The significant rise in the cases of orthopedic trauma conditions and cardiovascular diseases is the leading factor behind the growth of the global extracellular matrix market. As a part of the treatment, the extracellular matrix offers several benefits in treating different chronic injuries caused due to surgery, accidents, chronic diseases, and other incidents. Moreover, heart failure and myocardial infarction incidences are increasing among the aging population. The minimally invasive treatment for these cardiovascular treatments procedures requires an extracellular matrix. A patient suffering from heart disease fails to restore the functional properties of cardiac tissue. The extracellular matrix's ability to regrow and promote adaptive repair and regeneration enables patients to recover their normal functions. Also, it has shown promising clinical outcomes for tissue engineering in the treatment of cardiovascular diseases and other health conditions.
Furthermore, the rising incidences of cardiovascular diseases are expected to drive the growth of the extracellular matrix. For instance, according to WHO data published in 2019, an estimated 17.9 million people died from CVDs 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. According to the European Cardiovascular Disease Statistics report of 2017, in Europe, each year cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in the European Union (EU).
Raw Material-based Insights
Based on the raw material, the extracellular matrix market is segmented into bovine, porcine, and other raw materials. The porcine segment is expected to hold the largest share in the market, whereas, the bovine segment is expected to register the highest CAGR during the forecast period.
Extracellular Matrix Market, by Raw Material – 2021 and 2028
Get more information on this report :
Based on the application, the extracellular matrix market has been segmented into soft tissue repair, dural repair , wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. The soft tissue repair segment is likely to account for a larger market share in 2021. However, the vascular repair and reconstruction segment is expected to register a higher CAGR in the market during the forecast period.
Various companies operating in the extracellular matrix market are adopting marketing strategies, such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the increasing demand from end users.
Company Profiles
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
Frequently Asked Questions
The List of Companies - Extracellular Matrix Market
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the extracellular matrix market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global extracellular matrix market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount